DE3017221C2 - - Google Patents
Info
- Publication number
- DE3017221C2 DE3017221C2 DE3017221A DE3017221A DE3017221C2 DE 3017221 C2 DE3017221 C2 DE 3017221C2 DE 3017221 A DE3017221 A DE 3017221A DE 3017221 A DE3017221 A DE 3017221A DE 3017221 C2 DE3017221 C2 DE 3017221C2
- Authority
- DE
- Germany
- Prior art keywords
- ointment
- weight
- water
- component
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002674 ointment Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 235000010443 alginic acid Nutrition 0.000 claims description 30
- 229920000615 alginic acid Polymers 0.000 claims description 30
- 239000006185 dispersion Substances 0.000 claims description 28
- 150000002632 lipids Chemical class 0.000 claims description 27
- 239000013078 crystal Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 21
- 239000010410 layer Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- -1 alginic acid salt Chemical class 0.000 claims description 12
- 239000000783 alginic acid Substances 0.000 claims description 11
- 229960001126 alginic acid Drugs 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 159000000007 calcium salts Chemical class 0.000 claims description 9
- 239000011241 protective layer Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 210000004400 mucous membrane Anatomy 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000012071 phase Substances 0.000 claims description 4
- 230000007704 transition Effects 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 239000002502 liposome Substances 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 241000271915 Hydrophis Species 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 150000001447 alkali salts Chemical class 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 21
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 18
- 229940072056 alginate Drugs 0.000 description 18
- 238000003756 stirring Methods 0.000 description 10
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 7
- 239000001639 calcium acetate Substances 0.000 description 7
- 229960005147 calcium acetate Drugs 0.000 description 7
- 235000011092 calcium acetate Nutrition 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HAVHUGIUPJOKHX-UHFFFAOYSA-L disodium;tetradecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCOP([O-])([O-])=O HAVHUGIUPJOKHX-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-M hexadecyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)([O-])=O ZUVCYFMOHFTGDM-UHFFFAOYSA-M 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7904028A SE442705B (sv) | 1979-05-08 | 1979-05-08 | Medel for bildande av ett skyddsskikt pa ett underlag i form av hud eller slemhinna samt forfarande for att bilda ett skyddsskikt pa huden i icke-terapeutiskt syfte med hjelp av detta medel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3017221A1 DE3017221A1 (de) | 1980-11-20 |
| DE3017221C2 true DE3017221C2 (en:Method) | 1989-12-14 |
Family
ID=20337998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19803017221 Granted DE3017221A1 (de) | 1979-05-08 | 1980-05-06 | Verfahren und mittel zur herstellung einer schutzschicht auf einer haut oder schleimhaut |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4505935A (en:Method) |
| JP (1) | JPS562907A (en:Method) |
| DE (1) | DE3017221A1 (en:Method) |
| GB (1) | GB2049424B (en:Method) |
| SE (1) | SE442705B (en:Method) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695463A (en) * | 1985-05-24 | 1987-09-22 | Warner-Lambert Company | Delivery system for active ingredients and preparation thereof |
| MY101125A (en) * | 1985-12-23 | 1991-07-31 | Kao Corp | Gel-like emulsion and o/w emulsions obtained from gel-like emulsion |
| US5264422A (en) * | 1986-06-30 | 1993-11-23 | Fidia S.P.A. | Esters of alginic acid with steroidal alcohols |
| IT1203814B (it) * | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | Esteri dell'acido alginico |
| JPH0192468A (ja) * | 1986-08-20 | 1989-04-11 | Japan Small Business Corp | 検反装置 |
| US5133965A (en) * | 1988-06-08 | 1992-07-28 | Fountain Pharmaceuticals, Inc. | Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution |
| US5269979A (en) * | 1988-06-08 | 1993-12-14 | Fountain Pharmaceuticals, Inc. | Method for making solvent dilution microcarriers |
| US5174988A (en) * | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
| DE4140473C2 (de) * | 1991-12-09 | 1995-12-21 | Schuelke & Mayr Gmbh | Hautantiseptikum und Händedesinfektionsmittel |
| DE4240674C2 (de) * | 1992-11-26 | 1999-06-24 | Schuelke & Mayr Gmbh | Desodorierende Wirkstoffe |
| FR2779953B1 (fr) | 1998-06-22 | 2000-08-11 | Codif International Sa | Procede d'elaboration d'un produit cosmetique destine a proteger la peau contre les agressions resultant de la pollution de l'air ambiant |
| US6503488B1 (en) * | 1998-11-17 | 2003-01-07 | Tend Skin International, Inc. | Topical compositions including deodorant compositions |
| NZ530278A (en) * | 2001-06-01 | 2006-06-30 | Tendskin Company | Topical composition containing a salicylate derivative for veterinary use in treating dermatological disorders |
| US8535709B2 (en) * | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
| US20060127437A1 (en) * | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
| US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
| JP6358593B2 (ja) * | 2014-06-20 | 2018-07-18 | 三粧化研株式会社 | 皮膚化粧料 |
| WO2017048951A1 (en) * | 2015-09-16 | 2017-03-23 | Apeel Technology, Inc. | Precursor compounds for molecular coatings |
| EP3170533A1 (en) * | 2015-11-17 | 2017-05-24 | Welcare Research S.r.l. | Composition and kit for treatment of wounds |
| DE102015226167A1 (de) * | 2015-12-21 | 2017-06-22 | Henkel Ag & Co. Kgaa | Haarbehandlungs-Kit mit Hautschutzmittel |
| CN111118911A (zh) * | 2019-12-31 | 2020-05-08 | 合肥科天水性科技有限责任公司 | 一种生物基干法服装革贝斯及其制备方法 |
| MX2024002926A (es) | 2021-09-08 | 2024-03-26 | Apeel Tech Inc | Compuestos y formulaciones para recubrimientos protectores. |
| CN120230309A (zh) * | 2022-07-28 | 2025-07-01 | 康迪菲（苏州）生物科技有限公司 | 原位海藻酸钠水凝胶一次性手套的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE268489C (en:Method) * | 1911-11-23 | |||
| GB322607A (en) * | 1928-11-02 | 1929-12-12 | Tokujiro Hashimoto | Process of making toilet material |
| GB342947A (en:Method) * | 1929-03-27 | 1931-02-12 | The British Thomson-Houston Company Limited | |
| DE569520C (de) * | 1929-03-27 | 1933-02-04 | Aeg | Hautschutzmittel |
| DE932817C (de) * | 1952-08-17 | 1955-09-08 | Merz & Co | Verfahren zur Herstellung von aufgelockerten Salben |
| GB1050967A (en:Method) * | 1962-08-11 | |||
| FR1367858A (fr) * | 1962-08-11 | 1964-07-24 | Hoechst Ag | Bases de pommades pour les muqueuses et leur préparation |
| US5144441A (en) * | 1989-03-23 | 1992-09-01 | Thomson Consumer Electronics, Inc. | Quieting receiver during power interruption |
-
1979
- 1979-05-08 SE SE7904028A patent/SE442705B/sv not_active IP Right Cessation
-
1980
- 1980-05-06 DE DE19803017221 patent/DE3017221A1/de active Granted
- 1980-05-08 GB GB8015196A patent/GB2049424B/en not_active Expired
- 1980-05-08 JP JP6001680A patent/JPS562907A/ja active Granted
-
1982
- 1982-08-20 US US06/409,972 patent/US4505935A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB2049424A (en) | 1980-12-31 |
| DE3017221A1 (de) | 1980-11-20 |
| SE442705B (sv) | 1986-01-27 |
| US4505935A (en) | 1985-03-19 |
| JPS6318566B2 (en:Method) | 1988-04-19 |
| SE7904028L (sv) | 1980-11-09 |
| GB2049424B (en) | 1983-09-01 |
| JPS562907A (en) | 1981-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3017221C2 (en:Method) | ||
| DE2012775C3 (de) | Salbenfohe und Verfahren zu ihrer Herstellung | |
| DE1930957C3 (de) | Wasserlösliches Silbersalz enthaltendes Gel zur Behandlung von Verbrennungen | |
| CH672598A5 (en:Method) | ||
| DE69713912T2 (de) | Dehydrierte hydrogele | |
| DE3111767A1 (de) | Mittel zur behandlung der haut | |
| DE60122927T2 (de) | Hautcremezusammensetzung | |
| DE4007668A1 (de) | Hydrogelschaeume und verfahren zu deren herstellung | |
| DE3710293A1 (de) | Wasserfeste sonnenschutz-zusammensetzung | |
| DE69829510T2 (de) | Stabile Zubereitung enthaltend Acetylsalicylsäure und Siliconöl zur äusseren Anwendung | |
| DE2933250A1 (de) | Abdeckmaterial | |
| DE60020768T2 (de) | Heparin und Diclofenac enthaltendes topisches Pflaster | |
| DE69908375T9 (de) | Nimesulide-haltige topische arzneimittel | |
| DE69614110T2 (de) | Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung | |
| DE2300594C2 (de) | Hautbehandlungsmittel | |
| DE60011686T2 (de) | Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis | |
| DE3226753A1 (de) | Wundverband zur aufnahme von wundsekret | |
| DE1804801B2 (de) | Mittel zur aknebehandlung | |
| DE69018258T2 (de) | Aktive Bestandteile enthaltende phospholipidische Liposome und Verfahren zu ihrer Herstellung. | |
| DE102018132948A1 (de) | Verfahren zur Herstellung einer Hydrogelformulierung, eine Hydrogelfolie, Verfahren zur Herstellung dieser Hydrogelfolie und deren Verwendung | |
| DE19934585A1 (de) | Salbe zur Behandlung von dermatologischen Erkrankungen | |
| DE102005008299A1 (de) | Universalpflegecreme | |
| DE2852809C3 (de) | Grundlage für Salben und Cremes | |
| DE69320638T2 (de) | Topisches mittel | |
| DE3226754A1 (de) | Wundverband zur aufnahme von wundsekret |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: LARSSON, VIKTOR KAARE, PROF., BJAERRED, SE |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |